Edwards Lifesciences EPS - Earnings per Share 2010-2024 | EW

Edwards Lifesciences earnings per share (EPS) for the twelve months ending September 30, 2024 was $6.93, a 196.15% increase year-over-year.

  • Edwards Lifesciences EPS for the quarter ending September 30, 2024 was $5.13, a 714.29% increase year-over-year.
  • Edwards Lifesciences 2023 annual EPS was $2.3, a 5.74% decline from 2022.
  • Edwards Lifesciences 2022 annual EPS was $2.44, a 2.52% increase from 2021.
  • Edwards Lifesciences 2021 annual EPS was $2.38, a 83.08% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Edwards Lifesciences EPS - Earnings per Share 2010-2024 | EW

  • Edwards Lifesciences EPS for the quarter ending September 30, 2024 was $5.13, a 714.29% increase year-over-year.
  • Edwards Lifesciences 2023 annual EPS was $2.3, a 5.74% decline from 2022.
  • Edwards Lifesciences 2022 annual EPS was $2.44, a 2.52% increase from 2021.
  • Edwards Lifesciences 2021 annual EPS was $2.38, a 83.08% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$194.7B
Intuitive Surgical (ISRG)$191.9B
Alcon (ALC)$42.1B
IQVIA Holdings (IQV)$34.7B
IDEXX Laboratories (IDXX)$34.1B
DexCom (DXCM)$29.2B
STERIS (STE)$20.9B
Waters (WAT)$20.5B
SONOVA HOLDING (SONVY)$20.3B
Hologic (HOLX)$18.2B
Fresenius Medical Care AG KGaA (FMS)$13B
Sysmex ADR (SSMXY)$12.7B
Globus Medical (GMED)$11.3B
Penumbra (PEN)$9.1B
Teleflex (TFX)$9B
Masimo (MASI)$8.8B
Glaukos (GKOS)$8B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.5B
Veracyte (VCYT)$3B
Inari Medical (NARI)$3B
LivaNova (LIVN)$2.8B
TransMedics (TMDX)$2.8B
Nihon Kohden (NHNKY)$2.3B
Elekta AB (EKTAY)$2.2B
Tandem Diabetes Care (TNDM)$1.8B
RxSight (RXST)$1.8B
Integra LifeSciences Holdings (IART)$1.8B
Alphatec Holdings (ATEC)$1.4B
Artivion (AORT)$1.1B